We investigated whether exogenous SOD also enhanced the efficacy of sub-toxic DSF against Her2-overexpressing SKBR3 breast carcinoma which harbour a mutant p53 R175H [29, 41]. This evidence concerns the gene TP53 and breast carcinoma.